http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102350002-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-80 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-87 |
| filingDate | 2014-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102350002-B1 |
| titleOfInvention | Taxanes compounds, preparation method therefor, and uses thereof |
| abstract | The present invention provides a taxane compound having the structure of Formula (I) or Formula (II), a method for preparing the compound, and a pharmaceutically acceptable salt and solvate thereof for the preparation of an oral antitumor therapeutic agent as an active ingredient The use of the composition containing it is provided. In formula (I), R 1 is -COR 6 , -COOR 6 or -CONR 7a R 7b ; R 2 is C1-C6 alkyl, C1-C6 alkenyl, a substituted hydrocarbon group, a heterocyclyl group, an aromatic group or a substituted aromatic group; R 3 is -OR 6 , -OCOOR 6 , -OCOSR 6 or -OCONR 7a R 7b ; R 4 is -OR 6 , -OCOOR 6 , -OCOSR 6 , -OCONR 7a R 7b or H; wherein R 6 is C1-C6 alkyl, C1-C6 alkenyl, C1-C6 alkynyl, a substituted hydrocarbon group, an aromatic group or a heterocyclyl group; R 7a and R 7b is each hydrogen, a hydrocarbon group, a substituted hydrocarbon group or a heterocyclyl group. In formula (II), R 1 is -COR 6 or -COOR 6 ; R 2 is an aromatic group; R 3 is —OR 6 ; and R 6 is C1-C6 alkyl, C1-C6 alkenyl, C1-C6 alkynyl, a substituted hydrocarbon group, an aromatic group, or a heterocyclyl group. |
| priorityDate | 2013-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 185.